[Vaccination against human papillomavirus and against the cellular proliferation that it induces: facts and expectations].
Vaccination against human papillomavirus (HPV) give promising results in animal models. Prophylactic vaccination uses essentially virus-like particles autoassembled from the L1 capsid protein in its native form. Protection is achieved: it is efficient, type-specific and humoral. Therapeutic vaccination is of cellular origin and raised against the E7 oncoprotein. Several vaccine preparations have been found to be efficient: they include virus-like particles formed with L1-E7 fusion protein, E7 encoding plasmidic DNA, dendritic cells pulsed with E7-derived peptides,.